94 related articles for article (PubMed ID: 12579528)
1. Determination of intracellular efficacies of azithromycin against Leishmania major infection in human neutrophils in vitro.
Tanyuksel M; Bas AL; Araz E; Aybay C
Cell Biochem Funct; 2003 Mar; 21(1):93-6. PubMed ID: 12579528
[TBL] [Abstract][Full Text] [Related]
2. Antileishmanial activity of azithromycin against Leishmania (Leishmania) amazonensis, Leishmania (Viannia) braziliensis, and Leishmania (Leishmania) chagasi.
de Oliveira-Silva F; de Morais-Teixeira E; Rabello A
Am J Trop Med Hyg; 2008 May; 78(5):745-9. PubMed ID: 18458308
[TBL] [Abstract][Full Text] [Related]
3. Leishmania major and Leishmania tropica: I the in vitro effects of an immunomodulator, S2-Complex.
Al-Mulla Hummadi YM; Najim RA; Al-Bashir NM
Exp Parasitol; 2005 Sep; 111(1):47-54. PubMed ID: 15970286
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of peritoneal macrophage phagocytic activity against Leishmania major by garlic (Allium sativum) treatment.
Ghazanfari T; Hassan ZM; Khamesipour A
J Ethnopharmacol; 2006 Feb; 103(3):333-7. PubMed ID: 16213117
[TBL] [Abstract][Full Text] [Related]
5. Leishmania major: in vitro and in vivo anti-leishmanial effect of cantharidin.
Ghaffarifar F
Exp Parasitol; 2010 Oct; 126(2):126-9. PubMed ID: 20435039
[TBL] [Abstract][Full Text] [Related]
6. Modification of phagocytosis and cytokine production in peritoneal and splenic murine cells by erythromycin A, azithromycin and josamycin.
Ortega E; Escobar MA; Gaforio JJ; Algarra I; Alvarez De Cienfuegos G
J Antimicrob Chemother; 2004 Feb; 53(2):367-70. PubMed ID: 14729765
[TBL] [Abstract][Full Text] [Related]
7. Nuphar lutea: in vitro anti-leishmanial activity against Leishmania major promastigotes and amastigotes.
El-On J; Ozer L; Gopas J; Sneir R; Golan-Goldhirsh A
Phytomedicine; 2009 Aug; 16(8):788-92. PubMed ID: 19303752
[TBL] [Abstract][Full Text] [Related]
8. Activity of azithromycin against Leishmania major in vitro and in vivo.
Krolewiecki A; Leon S; Scott P; Abraham D
Am J Trop Med Hyg; 2002 Sep; 67(3):273-7. PubMed ID: 12408666
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological evaluation of anti-leishmanial activity by in vivo nitric oxide modulation in Balb/c mice infected with Leishmania major MRHO/IR/75/ER: an Iranian strain of cutaneous leishmaniasis.
Nahrevanian H; Farahmand M; Aghighi Z; Assmar M; Amirkhani A
Exp Parasitol; 2007 Jul; 116(3):233-40. PubMed ID: 17335813
[TBL] [Abstract][Full Text] [Related]
10. Immunomodulatory effect of Canova medication on experimental Leishmania amazonensis infection.
Pereira WK; Lonardoni MV; Grespan R; Caparroz-Assef SM; Cuman RK; Bersani-Amado CA
J Infect; 2005 Aug; 51(2):157-64. PubMed ID: 16038768
[TBL] [Abstract][Full Text] [Related]
11. [The influence of antibiotics on phagocytic and bacteriocidal activity of rabbit peritoneal macrophages stimulated by filtrates of cultured t-lymphocytes].
Sacha PT; Zaremba ML; Jakoniuk P
Med Dosw Mikrobiol; 1999; 51(3-4):399-412. PubMed ID: 10803270
[TBL] [Abstract][Full Text] [Related]
12. Cyclosporin A enhances elimination of intracellular L. major parasites by murine macrophages.
Bogdan C; Streck H; Röllinghoff M; Solbach W
Clin Exp Immunol; 1989 Jan; 75(1):141-6. PubMed ID: 2702771
[TBL] [Abstract][Full Text] [Related]
13. Selective leishmanicidal effect of 1,3,4-thiadiazole derivatives and possible mechanism of action against Leishmania species.
Poorrajab F; Ardestani SK; Foroumadi A; Emami S; Kariminia A; Behrouzi-Fardmoghadam M; Shafiee A
Exp Parasitol; 2009 Apr; 121(4):323-30. PubMed ID: 19124020
[TBL] [Abstract][Full Text] [Related]
14. Infectivity of five different types of macrophages by Leishmania infantum.
Maia C; Rolão N; Nunes M; Gonçalves L; Campino L
Acta Trop; 2007 Aug; 103(2):150-5. PubMed ID: 17626776
[TBL] [Abstract][Full Text] [Related]
15. Effects of anti-Leishmania monoclonal antibodies on the development of Leishmania major in Phlebotomus duboscqi (Diptera: Psychodidae).
Anjili C; Langat B; Ngumbi P; Mbati PA; Githure J; Tonui WK
East Afr Med J; 2006 Feb; 83(2):72-8. PubMed ID: 16708877
[TBL] [Abstract][Full Text] [Related]
16. Impairment of Leishmania mexicana phagocytosis in peritoneal macrophages induced by Amaranthus leucocarpus lectin.
Gorocica P; Hernández P; Perez A; Chávez R; Baez R; Zenteno E; Lascurain R
Immunol Invest; 2000 Nov; 29(4):373-82. PubMed ID: 11130780
[TBL] [Abstract][Full Text] [Related]
17. Studies on the effect of the anti-phagocytic agent cytochalasin B on Leishmania-macrophage interaction.
Ardehali SM; Khoubyar K; Rezai HR
Acta Trop; 1979 Mar; 36(1):15-21. PubMed ID: 35930
[TBL] [Abstract][Full Text] [Related]
18. Tamoxifen is effective against Leishmania and induces a rapid alkalinization of parasitophorous vacuoles harbouring Leishmania (Leishmania) amazonensis amastigotes.
Miguel DC; Yokoyama-Yasunaka JK; Andreoli WK; Mortara RA; Uliana SR
J Antimicrob Chemother; 2007 Sep; 60(3):526-34. PubMed ID: 17584801
[TBL] [Abstract][Full Text] [Related]
19. Bioluminescent Leishmania expressing luciferase for rapid and high throughput screening of drugs acting on amastigote-harbouring macrophages and for quantitative real-time monitoring of parasitism features in living mice.
Lang T; Goyard S; Lebastard M; Milon G
Cell Microbiol; 2005 Mar; 7(3):383-92. PubMed ID: 15679841
[TBL] [Abstract][Full Text] [Related]
20. Spontaneous recovery of pathogenicity by Leishmania major hsp100-/- alters the immune response in mice.
Reiling L; Jacobs T; Kroemer M; Gaworski I; Graefe S; Clos J
Infect Immun; 2006 Nov; 74(11):6027-36. PubMed ID: 17057085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]